Company / PP&E per Share
Quest Diagnostics PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$19.50
FY2025
5-year range
$12.55 / $19.50
FY2021-FY2025
Trend
+8.9%
vs FY2024
Sector context
#17 of 130
Health Care
What the data says
Quest Diagnostics's pp&e per share of $19.50 is higher than 87% of companies in the Health Care sector (FY2025). PP&E per Share has increased for 9 consecutive years, from $7.10 in FY2016 to $19.50 in FY2025.
Based on SEC 10-K filings.
19.50 in FY2025 with a 5-year CAGR of +10.7%. Top quartile in the Health Care sector.
Improved from $14.19 to $19.50 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +10.7%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 130This company $19.50 Sector average $11.80
▼
+65.3% above sector average
Key checks
Key Insights
- Quest Diagnostics's pp&e per share has grown for 9 consecutive years.
- In FY2025, pp&e per share increased 8.9% year-over-year.
- Ranks #17 out of 130 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.50 | +8.9% |
| FY2024 | $17.91 | +26.2% |
| FY2023 | $14.19 | +9.3% |
| FY2022 | $12.99 | +3.5% |
| FY2021 | $12.55 | +7.2% |
| FY2020 | $11.71 | +12.8% |
| FY2019 | $10.38 | +14.4% |
| FY2018 | $9.07 | +14.9% |
| FY2017 | $7.90 | +11.3% |
| FY2016 | $7.10 | +17.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026